Case Reports in Obstetrics and Gynecology

Case Reports in Obstetrics and Gynecology / 2018 / Article

Case Report | Open Access

Volume 2018 |Article ID 2039730 | https://doi.org/10.1155/2018/2039730

Sotirios Tsiodras, Alina-Roxani Gouloumi, Zoi Tsakiraki, George Chrelias, Charalambos Chrelias, Stylianos Loukides, Ioannis Panayiotides, "Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites", Case Reports in Obstetrics and Gynecology, vol. 2018, Article ID 2039730, 3 pages, 2018. https://doi.org/10.1155/2018/2039730

Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites

Academic Editor: Julio Rosa-e-Silva
Received25 Jul 2017
Revised21 Nov 2017
Accepted14 Dec 2017
Published22 Jan 2018

Abstract

A rare case of ovarian sarcoidosis with peritoneal and omental involvement presenting as an ovarian malignancy is presented. Clinical, laboratory, and radiological evaluation of the patient revealed ascites and high levels of serum CA 125 and CA 15.3. The diagnosis of sarcoidosis was confirmed with pathology findings on tissues obtained during surgical laparotomy. Establishing the diagnosis of sarcoidosis can be treacherous and was complicated in this case by the falsely elevated biomarkers and ascites.

1. Introduction

Atypical manifestations of sarcoidosis occurring outside typically affected organs make histology necessary in establishing the diagnosis after excluding infectious and neoplastic mimics of the disease. Extrapulmonary sarcoidosis has been reported in several sites; however localization of the disease in the female reproductive system is extremely rare accounting for less than 1% of cases [1]. Herein we present a rare case of ovarian sarcoidosis with peritoneal and omental involvement presenting as ovarian malignancy with falsely elevated cancer biomarkers.

2. Case Presentation

A 79-year-old, gravida 4, para 2, Caucasian female with a history of weight loss and fatigue for 4 months was referred to our hospital for investigation of her symptoms. Medical history was significant for dyslipidemia and hypertension treated with irbesartan. The physical examination disclosed no abnormalities. Due to concern for malignancy, diagnostic imaging was performed. Chest X-ray was negative. Ultrasound, CT, and MRI of the abdominal area showed the presence of minimal amounts of free liquid in the perihepatic area, in the paracolic sulci, in the right inguinal region, and in the pouch of Douglas, without the involvement of retroperitoneal, paraaortic, and iliac chain lymph nodes. Since the suspicion of malignancy remained high, the gynaecology team ordered cancer biomarkers; testing disclosed a CA 125 value of 225.20 U/ml (normal range < 35 U/ml) and a CA 15.3 value of 73.9 U/ml (normal values < 35 U/ml). Levels of carcinoembryonic antigen were within normal range; that is, CEA levels were 1.43 ng/ml (normal values < 3 ng/ml) and carbohydrate antigen 19-9 (CA 19-9) levels were 6,4 U/ml (normal values < 37 U/ml). Cytological examination of the ThinPrep® sample obtained via a transvaginal fine-needle aspiration was negative for malignancy only disclosing an abundance of histiocytes, lymphocytes, white blood cells, and few mesothelial and red blood cells. An exploratory laparotomy was performed; multiple grey-white miliary nodular lesions with a diameter ranging from 0.2 to 1.6 cm were observed on the surface of the left ovary, the uterus, the peritoneum, the omentum, and the small and large intestine. Histological examination of omental and peritoneal biopsies disclosed the presence of noncaseating, nonnecrotic, sarcoid type granulomas containing multinucleated giant cells (Figures 1 and 2). Moreover, the left ovary contained, upon sections, a whitish area consisting of cytopenic fibrous connective tissue (Figure 2) containing a single multinucleated giant cell (Figure 3), thus corresponding to a focus of fibrosed granuloma. Histochemical stains (PAS, Grocott’s silver impregnation, and Ziehl-Neelsen) disclosed no fungi, argyrophilic, or acid-fast microorganisms.

The final histological diagnosis was granulomatous, sarcoid type inflammation. Evaluation by an expert pulmonologist revealed no evidence of lung sarcoidosis by CT scan and gallium scanning. The patient was further investigated in the direction of possible extra pulmonary involvement with no abnormal findings revealed. A decision to withhold further therapy was made. The patient is doing well after one year of follow-up without other complications.

3. Discussion

There was neither family history of sarcoidosis, nor history of immunodeficiency or biological factor therapy. Furthermore, the patient did not mention any occupational or environmental exposure in industrial work associated with beryllium; such exposure has been associated with granuloma formation, pulmonary sarcoidosis, and elevations of Serum Angiotensin-Converting Enzyme (SACE) activity [2]. No history of prior infections due to mycobacterial or cutibacteria (aka propionibacteria) was reported; such infections have been etiologically implicated in the pathogenesis of sarcoidosis [3, 4].

Histology confirmation is necessary for the diagnosis of sarcoidosis occurring outside usually affected organs, for example, the lung. In any case the physician needs to exclude the presence of infectious or neoplastic mimics of the disease. Sarcoidosis has been very rarely described to affect the female genital tract especially the ovaries and even more rarely in relation to a concomitant malignancy [57].

In our case peritoneal involvement was also noted which has been described more frequently [810]. In some reports sarcoidosis presented as a peritoneal malignancy [9, 11]. Involvement of both organs at the same time as was the case in our patient appears to be even rarer [12, 13]. In contrast to our case where weight loss and fatigue were the presenting symptoms, common features of female genital tract sarcoidosis include the presence of abdominal pain and abdominal distension as well as menstrual cycle disturbances. No radiological or nuclear findings are specific to this disease location [14]. The free fluid in the abdominal cavity directed the diagnostic work-up towards the presence of a neoplastic disease. In retrospect, the peritoneal involvement in our case explains the ascites; sarcoidosis of the peritoneum has been described to mimic other neoplasias such as peritoneal carcinomatosis [15].

With regard to the elevated biomarkers the abnormal CA-125 levels are explained by the presence of peritoneal involvement and ascites and have been previously described [10, 16]. It is well known that, besides gynaecological cancers, CA 125 levels are elevated also in various nongynecologic malignancies and other benign conditions [10]. In contrast, we identified only one other case where sarcoidosis of the breast was found after breast operation with a minimal elevation of CA 15.3 of 31.6 U/ml [17]. Abnormal CA 15.3 levels have been correlated with a wide range of cancers, including breast cancer; its use has been proposed as a disease marker in (fibrotic) pulmonary sarcoidosis that was not observed in our case [18].

In our report surgical intervention led to the correct diagnosis. Similarly, in previous reports, a provisional diagnosis of ovarian malignancy was excluded by exploratory laparotomy and histological confirmation of sarcoidosis [6, 13, 19].

In conclusion, we describe a rare case of ovarian, peritoneal, and omental sarcoidosis with no lung involvement and abnormally elevated CA 15-3 levels. Cancer biomarkers should not be used to exclude or confirm the diagnosis of cancer or sarcoidosis for the same matter. In our case their use misled the physicians in assuming the presence of a gynecological malignancy. Histological confirmation of the diagnosis is necessary in such difficult cases.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. S. I. Rosenfeld, W. Steck, and J. L. Breen, “Sarcoidosis of the female genital tract: a case presentation and survey of the world literature,” International Journal of Gynecology and Obstetrics, vol. 28, no. 4, pp. 373–380, 1989. View at: Publisher Site | Google Scholar
  2. L. S. Newman, R. Orton, and K. Kreiss, “Serum angiotensin converting enzyme activity in chronic beryllium disease,” American Review of Respiratory Disease, vol. 146, no. 1, pp. 39–42, 1992. View at: Publisher Site | Google Scholar
  3. G. Mangiapan and A. J. Hance, “Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data.,” Sarcoidosis Vasculitis and Diffuse Lung Diseses, vol. 12, no. 1, pp. 20–37, 1995. View at: Google Scholar
  4. I. C. Mitchell, J. L. Turk, and D. N. Mitchell, “Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation,” The Lancet, vol. 339, no. 8800, pp. 1015–1017, 1992. View at: Publisher Site | Google Scholar
  5. J. H. Isaacs, M. P. MacLaverty, and J. J. Polich, “Boeck’s sarcoid of the uterus and associated carcinoma in situ of the cervix: Report of a case,” Obstetrics & Gynecology, vol. 24, no. 1, pp. 89–92, 1964. View at: Google Scholar
  6. A. White, N. Flaris, D. Elmer, R. Lui, and B. L. Fanburg, “Coexistence of mucinous cystadenoma of the ovary and ovarian sarcoidosis,” American Journal of Obstetrics & Gynecology, vol. 162, no. 5, pp. 1284-1285, 1990. View at: Publisher Site | Google Scholar
  7. R. Wuntakal, R. Bharathan, A. Rockall, and A. Jeyarajah, “Interesting case of ovarian sarcoidosis: The value of multi disciplinary team working,” World Journal of Surgical Oncology, vol. 5, article no. 38, 2007. View at: Publisher Site | Google Scholar
  8. L. Bourdillon, E. Lanier-Gachon, K. Stankovic et al., “Löfgren syndrome and peritoneal involvement by sarcoidosis: Case report,” CHEST, vol. 132, no. 1, pp. 310–312, 2007. View at: Publisher Site | Google Scholar
  9. J. V. Brown III, H. D. Epstein, M. Chang, and B. H. Goldstein III, “Sarcoidosis presenting as an intraperitoneal mass,” Case Reports in Oncology, vol. 3, no. 1, pp. 9–13, 2010. View at: Publisher Site | Google Scholar
  10. E. L. Trimble, P. E. Saigo, G. W. Freeberg, S. C. Rubin, and W. J. Hoskins, “Peritoneal sarcoidosis and elevated CA 125,” Obstetrics & Gynecology, vol. 78, no. 5, pp. 976-977, 1991. View at: Google Scholar
  11. U. Netz, Z. H. Perry, M. Y. Bayme, V. Dyomin, and S. Mizrahi, “Primary peritoneal sarcoidosis causing an omental cake,” The American Surgeon, vol. 79, E6, no. 1, p. E9, 2013. View at: Google Scholar
  12. F. Fuchs, A. Le Tohic, P. Raynal et al., “Ovarian and peritoneal sarcoidosis mimicking an ovarian cancer,” Gynecologie Obstetrique et Fertilite, vol. 35, no. 1, pp. 41–44, 2007. View at: Publisher Site | Google Scholar
  13. K. Karmaniolas, S. Liatis, M. Dalamaga, G. Mourouti, A. Digeni, and I. Migdalis, “A case of ovarian sarcoidosis mimicking malignancy,” European Journal of Gynaecological Oncology, vol. 26, no. 2, pp. 231-232, 2005. View at: Google Scholar
  14. R. Turkay, B. Bakir, U. C. Golabi, S. Topuz, and H. R. Ilhan, “Vanishing ovarian mass: Sarcoidosis,” Radiology Case Reports, vol. 7, no. 3, 2012. View at: Publisher Site | Google Scholar
  15. A. Nicolini, M. Vita, and S. Lanata, “Peritoneal sarcoidosis: an unusual presentation and a brief review of the literature,” in Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, vol. 75, pp. 132–134, Fondazione clinica del lavoro, IRCCS and Istituto di Clinica Tisiologica E Malattie Apparato Respiratorio, Universita Di Napoli, Secondo Ateneo, 2011. View at: Google Scholar
  16. M. Kalluri and M. A. Judson, “Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature,” The American Journal of the Medical Sciences, vol. 334, no. 6, pp. 441–443, 2007. View at: Publisher Site | Google Scholar
  17. F. Fiorucci, V. Conti, G. Lucantoni et al., “Sarcoidosis of the breast: A rare case report and a review,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 2, pp. 47–50, 2006. View at: Google Scholar
  18. A. Kruit, W. B. M. Gerritsen, N. Pot, J. C. Grutters, J. M. M. Van Den Bosch, and H. J. T. Ruven, “CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases,” Sarcoidosis Vasculitis and Diffuse Lung Diseses, vol. 27, no. 2, pp. 138–146, 2010. View at: Google Scholar
  19. A. S. Parveen, H. Elliott, and R. Howells, “Sarcoidosis of the ovary,” Journal of Obstetrics & Gynaecology, vol. 24, no. 4, article 465, 2004. View at: Publisher Site | Google Scholar

Copyright © 2018 Sotirios Tsiodras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views2705
Downloads575
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.